Investor Relations

3rd QUARTER 2023


Evonik has published its quarterly report Q3 2023 on November 7, 2023. 

You can access further information here.

  • Adj. EBITDA of €485 m well above Q2 level
  • Weak economic environment offset by positive market momentum in Animal Nutrition
    and contingency support
  • Contingency measures on track and to be extended into 2024
  • Cash generation picking up strongly with FCF of €469 m in Q3
  • Adj. EBITDA outlook for FY 2023 of €1.6 to 1.8 bn confirmed

Reporting 3rd Quarter 2023

Link / PDF
Analyst & Investor Factsheet
Presentation Conference Call

Detailed overview of key financial data (Evonik Financials) - as PDF

Detailed overview of key financial data (Evonik Financials) - as Excel

Quarterly Statement Q3 2023

Investor Relations News Q3 2023

Analysts' consensus* (Vara Research)

Webcast Conference Call Q3 2023
(November 7, 2023, 11.00 a.m. CET)

* The consensus is not controlled, changed or censored by Evonik Industries AG. Evonik Industries AG assumes no liability for the accuracy and completeness of these estimates and undertakes no obligation to update or revise such estimates and consensus data, even if they differ from Evonik Industries AG’s own forecasts or expectations. Evonik Industries AG is neither involved in the collection of the data, nor in the preparation of the consensus. This is done independently by Vara Research.